NAD+

A provider-directed sermorelin injection format for longevity programs that want a peptide-forward nightly routine with consults, refill review, and recurring membership infrastructure.

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). FDA orphan-drug records show sermorelin acetate (Geref) received marketing approval in 1997 for pediatric growth hormone deficiency. Modern longevity programs typically position sermorelin injection as a provider-directed, off-label peptide workflow with conservative expectations and regular follow-up.
Injection usually appeals to brands that already run peptide or hormone-adjacent memberships. It gives a stronger protocol signal than a tablet format, but it also asks more of onboarding, patient education, and refill oversight.
FDA orphan-drug records list Geref (sermorelin acetate) as approved on September 26, 1997; many modern sermorelin clinic offers are provider-directed compounded workflows rather than a current branded product.
The cleanest operator setup is to keep the public page focused on workflow and let the exact protocol live inside provider review. That preserves flexibility while giving patients a clear onboarding experience.
Use these charts to compare how the injection format usually behaves operationally versus a sermorelin tablet program. They are meant for planning the patient journey, not as efficacy claims.
Illustrative operator-planning view based on onboarding complexity, patient training, and refill behavior. Not a statement of safety or efficacy.
Launch the route, keep your own brand, and let the backend handle intake, provider review, billing, refill ops, and patient messaging in one place.
The platform ships the intake, subscriptions, refill workflows, billing, and patient communications β so your team can launch the program on top of one backend instead of stitching vendors together.
Marketing and educational content only. Clinical details on this page are summarized from publicly available sources to help operators scope a program β they are not medical advice, dosing instructions, or a recommendation for any individual patient. Real patient care requires a licensed provider and a compliant pharmacy partner; Turbopills provides the software that helps brands run the program around them.